B44.81

Clinical Causes: Allergic reaction to Aspergillus fumigatus or other Aspergillus species Pre-existing respiratory conditions such as asthma or cystic fibrosis Environmental exposure to Aspergillus spores, often found in soil, decaying vegetation, or damp environments Immune system hypersensitivity that triggers an exaggerated inflammatory response upon exposure

Key Symptoms: Wheezing and shortness of breath Cough, which may produce sputum Fever, particularly during exacerbations Chest tightness or discomfort Clubbing of fingers (in some cases) Fatigue and general malaise Repeated episodes of lung infiltrates visible on imaging

Diagnosis Path: Diagnosing ABPA involves a combination of clinical evaluation, laboratory tests, and imaging studies, including: - Blood tests showing elevated IgE levels and eosinophil counts - Skin prick testing or specific IgE antibodies against Aspergillus - Sputum analysis for Aspergillus spores or hyphae - Chest imaging, such as X-rays or CT scans, revealing characteristic infiltrates or mucus plugging - Exclusion of other lung conditions to confirm the allergic nature of symptoms These diagnostic steps help differentiate ABPA from other respiratory illnesses with similar presentations.

Treatment Protocols: Management of ABPA primarily aims to control the allergic inflammatory response and prevent lung damage. Common approaches include: - Corticosteroids to reduce lung inflammation - Antifungal medications, such as itraconazole, to decrease Aspergillus burden - Regular monitoring of lung function and IgE levels - Minimizing exposure to environmental Aspergillus spores - In some cases, immunotherapy or biologics may be considered for refractory symptoms - Supportive care, including inhalers and bronchodilators, as needed While treatment can effectively manage symptoms and reduce exacerbation frequency, ongoing follow-up is essential to monitor disease progression.